This topic contains a solution. Click here to go to the answer

Author Question: The nurse is caring for a patient with neurogenic diabetes insipidus and administers what drug to ... (Read 78 times)

vicky

  • Hero Member
  • *****
  • Posts: 586
The nurse is caring for a patient with neurogenic diabetes insipidus and administers what drug to treat the condition?
 
  A) Dexamethasone (Decadron)
  B) Desmopressin (DDAVP, Stimate)
  C) Methylprednisolone (Solu-Medrol)
  D) Physostigmine (Antilirium)

Question 2

A patient, newly diagnosed with chronic obstructive pulmonary disease (COPD), calls the clinic and asks the nurse to explain what the newly prescribed medications are for. What would be the most appropriate response by the nurse?
 
  A) The medications that have been ordered for you are what the physician thinks will help you the most.
  B) The medications that have been ordered for you are to help you breathe easier.
  C) The medications that have been ordered for you are designed to work together to help you feel better.
  D) The medications that have been ordered for you are to help relieve the inflammation and promote dilation of the bronchi.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Missbam101

  • Sr. Member
  • ****
  • Posts: 341
Answer to Question 1

B
Feedback:
Synthetic preparations of antidiuretic hormone (ADH), which are purer and have fewer adverse effects, are used to treat diabetes insipidus. Only one ADH preparation is currently available, desmopressin. Dexamethasone, methylprednisolone, and physostigmine would not be indicated for treatment of this disorder.

Answer to Question 2

D
Feedback:
Drug treatment of asthma and COPD aims to relieve inflammation and promote bronchial dilation. The other options do not give the patient information about the use of these new medications.




vicky

  • Member
  • Posts: 586
Reply 2 on: Jul 23, 2018
Gracias!


mjenn52

  • Member
  • Posts: 351
Reply 3 on: Yesterday
Excellent

 

Did you know?

The first monoclonal antibodies were made exclusively from mouse cells. Some are now fully human, which means they are likely to be safer and may be more effective than older monoclonal antibodies.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

Did you know?

Medication errors are more common among seriously ill patients than with those with minor conditions.

Did you know?

Though Candida and Aspergillus species are the most common fungal pathogens causing invasive fungal disease in the immunocompromised, infections due to previously uncommon hyaline and dematiaceous filamentous fungi are occurring more often today. Rare fungal infections, once accurately diagnosed, may require surgical debridement, immunotherapy, and newer antifungals used singly or in combination with older antifungals, on a case-by-case basis.

Did you know?

Glaucoma is a leading cause of blindness. As of yet, there is no cure. Everyone is at risk, and there may be no warning signs. It is six to eight times more common in African Americans than in whites. The best and most effective way to detect glaucoma is to receive a dilated eye examination.

For a complete list of videos, visit our video library